Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JNJ-53718678 + JNJ-64417184
- Development stage
- Unknown
- Lead developer
- Janssen Research & Development
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
JNJ-53718678 + JNJ-64417184 is an **oral combination of two investigational small molecules** being developed for the treatment of **respiratory syncytial virus (RSV) infection**. JNJ-53718678 is a **fusion inhibitor**, which blocks the fusion of the virus with host cell membranes, inhibiting viral entry and propagation. JNJ-64417184 is a **viral polymerase inhibitor**, targeting the production of viral proteins and thereby blocking replication. Both compounds have demonstrated activity against RSV by different mechanisms, and combination therapy is hypothesized to improve antiviral efficacy by targeting two essential steps in the viral life cycle. Both drugs are in early-phase clinical trials and have been primarily studied by Janssen (Johnson & Johnson companies)[1][3][4][7][10].
- Other names
- JNJ-8678 + JNJ-64417184
02
Targets
RSV F (Respiratory syncytial virus fusion protein)
Beyond the preview
Go deeper on JNJ-53718678 + JNJ-64417184.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JNJ-53718678 + JNJ-64417184.